XML 25 R10.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Intangible Assets
3 Months Ended
Mar. 31, 2019
Intangible Assets  
Intangible Assets

Note 4: INTANGIBLE ASSETS

 

Intangible assets that are subject to amortization are reviewed for potential impairment whenever events or circumstances indicate that carrying amounts may not be recoverable. Assets not subject to amortization are tested for impairment at least annually. The Company has intangible assets subject to amortization as described in the next paragraph. These costs were included in intangible assets on the balance sheet and amortized as indicated in the next paragraph. The Company will periodically review these and other intangible assets for impairment that it may acquire whenever events or changes in circumstances indicate that the carrying amount of the assets may not be fully recoverable. The Company will recognize an impairment loss when the sum of expected undiscounted future cash flows is less that the carrying amount of the asset, to be measured as the difference between the asset’s estimated fair value and its book value.

 

On June 8, 2018, the Company acquired certain patents and patent applications, a trademark and an internet domain related to “Medtainer®” pursuant to an Asset Purchase Agreement, dated as of April 16, 2018, and amended on June 8, 2018, by and between the Company and an unrelated party, in consideration of the issuance of 2,631,252 shares of common stock. These assets and the associated goodwill have been apportioned as follows, based upon a report that the Company obtained from an independent valuation firm:

 

Estimated Asset Valuation at March 31, 2019:

 

    Weighted Average   Gross Carrying   Accumulated    
Description   Estimated Useful Life   Value   Amortization   Net Amount
Certain U.S. patents   15 years   $ 435,000     $ (23,188 )   $ 411,812  
Certain U.S. patents   15 years     435,000       (22,315 )     412,685  
Certain Canadian                            
patents   20 years     260,000       (10,521 )     249,479  
Certain European                            
patents   14 years     30,000       (1,697 )     28,303  
Molds   15 years     150,000       (7,995 )     142,005  
Trademark   Indefinite life     220,000       —         220,000  
Domain name   Indefinite life     2,000       —         2,000  
Intangible Totals       $ 1,532,000     $ (65,716 )   $ 1,466,284  
Goodwill       $ 1,020,314     $ —       $ 1,020,314  

 

Estimated Asset Valuation at December 31, 2018:

 

    Weighted Average   Gross Carrying   Accumulated    
Description   Estimated Useful Life   Value   Amortization   Net Amount
Certain U.S. patents   15 years   $ 435,000     $ (16,060 )   $ 418,940  
Certain U.S. patents   15 years     435,000       (15,455 )     419,545  
Certain Canadian patents   20 years     260,000       (7,286 )     252,714  
Certain European patents   14 years     30,000       (1,175 )     28,825  
Molds   15 years     150,000       (5,538 )     144,462  
Trademark   Indefinite life     220,000       —         220,000  
Domain name   Indefinite life     2,000       —         2,000  
Intangible Totals       $ 1,532,000     $ (45,514 )   $ 1,486,486  
Goodwill       $ 1,020,314     $ —       $ 1,020,314